Literature DB >> 16122631

Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.

Hirokazu Arakawa1, Yukihiro Yuhara, Makoto Todokoro, Masahiko Kato, Hiroyuki Mochizuki, Kenichi Tokuyama, Fumio Kunimoto, Akihiro Morikawa.   

Abstract

We report an 11-year-old boy with apparently the motor axonal form of Guillain-Barre syndrome (GBS) who presented with severe paralysis and respiratory insufficiency by the 3rd day from onsets of symptoms. His serum anti-Mycoplasma pneumoniae and anti-Galactocerebroside (Gal-C) IgM antibody were significantly elevated. Magnetic resonance imaging, following contrast injection, showed enhancement of the cauda equina. The patient responded quickly and dramatically to immunoadsorption therapy using a tryptophan-immobilized column, with recovery of respiratory failure and muscle strength, dominantly in the left extremities. Immunoadsorption therapy should be considered for patients with anti Gal-C antibody-associated GBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16122631     DOI: 10.1016/j.braindev.2004.09.013

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Guillain-Barré syndrome in two patients with respiratory failure and a review of the Japanese literature.

Authors:  Erei Sohara; Takeshi Saraya; Kojiro Honda; Atsuko Yamada; Toshiya Inui; Yukari Ogawa; Mitsuru Sada; Naoki Tsujimoto; Masuo Nakamura; Akiko Tsuchiya; Masaki Saito; Chizuko Oishi; Atsuro Chiba; Hajime Takizawa; Hajime Goto
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

2.  Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies.

Authors:  Alexander J Davies; Janev Fehmi; Makbule Senel; Hayrettin Tumani; Johannes Dorst; Simon Rinaldi
Journal:  J Clin Med       Date:  2020-06-27       Impact factor: 4.241

3.  Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?

Authors:  Patrick M Meyer Sauteur; Bart C Jacobs; Emiel B M Spuesens; Enno Jacobs; David Nadal; Cornelis Vink; Annemarie M C van Rossum
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

4.  Guillain-Barré Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid.

Authors:  Sho Nishiguchi; Joel Branch; Tsubasa Tsuchiya; Ryoji Ito; Junya Kawada
Journal:  Am J Case Rep       Date:  2017-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.